The management of patients with gestational trophoblastic neoplasia based on the antigenic properties of human chorionic gonadotropin.
D001681:Biological Assay; D002822:Choriocarcinoma / Q000097:blood / Q000188:drug therapy*; D006063:Chorionic Gonadotropin / Q000097:blood*; D003609:Dactinomycin / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000097:blood / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000097:blood; D008722:Methods; D009362:Neoplasm Metastasis; D010060:Ovulation; D011247:Pregnancy; D011863:Radioimmunoassay; D012075:Remission, Spontaneous; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy*
D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D007986:Luteinizing Hormone